Invenio Wealth Partners’s Eli Lilly LLY Stock Holding History

Invenio Wealth Partners’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.06M	Sell	1,152 -60	-5%	-$60.8K	0.42%	34
2025 Q4	$1.3M	Sell	1,212 -104	-8%	-$99.4K	0.48%	32
2025 Q3	$1M	Sell	1,316 -32	-2%	-$23.8K	0.37%	39
2025 Q2	$1.05M	Sell	1,348 -216	-14%	-$168K	0.42%	36
2025 Q1	$1.29M	Sell	1,564 -45	-3%	-$37.4K	0.54%	31
2024 Q4	$1.24M	Buy	1,609 +98	+6%	+$81.1K	0.52%	34
2024 Q3	$1.34M	Buy	1,511 +297	+24%	+$267K	0.58%	30
2024 Q2	$1.1M	Sell	1,214 -20	-2%	-$16K	0.54%	30
2024 Q1	$960K	Sell	1,234 -343	-22%	-$244K	0.52%	33
2023 Q4	$919K	Sell	1,577 -194	-11%	-$113K	0.66%	32
2023 Q3	$951K	Sell	1,771 -58	-3%	-$29.9K	0.87%	29
2023 Q2	$858K	Buy	+1,829	New	+$767K	0.97%	23

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invenio Wealth Partners's LLY Position: Q1 2026 in Review

Invenio Wealth Partners reduced its Eli Lilly (LLY) stake by 5% in Q1 2026, selling an estimated $60.8K and leaving 1,152 shares worth $1.06M. The position accounts for 0.42% of the portfolio, ranked #34.

Invenio Wealth Partners first reported a position in LLY in Q2 2023 and has held it in 12 quarters since. The position peaked at $1.34M in Q3 2024. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Invenio Wealth Partners held 1,152 shares of Eli Lilly worth $1.06M as of Q1 2026.
Invenio Wealth Partners sold 60 Eli Lilly shares in Q1 2026, an estimated $60.8K.
Eli Lilly made up 0.42% of Invenio Wealth Partners's portfolio in Q1 2026, its #34 holding.
Invenio Wealth Partners first reported a position in Eli Lilly in Q2 2023 and has held it in 12 quarters since.
Invenio Wealth Partners's Eli Lilly position peaked at $1.34M in Q3 2024.
4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Invenio Wealth Partners's 13F filing for Q1 2026, filed 14 Apr 2026.